Morris D L, Jordan S D, Holsapple M P
Medical College of Virginia/Virginia Commonwealth University, Richmond 23298.
Immunopharmacology. 1991 May-Jun;21(3):159-69. doi: 10.1016/0162-3109(91)90021-p.
We have determined that suppression of the in vitro T-dependent humoral immune response by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on the type and concentration of serum used in the culture media. Only five out of 23 commercial lots of serum (screened at both 5 and 10%) could support a suppression in the presence of 30 nM TCDD, with the remaining lots demonstrating an apparent 'protective-like' effect against the TCDD exposure. When log dose response curves were established with TCDD (0.3, 3.0, and 30 nM) in media containing each of the serum lots supporting a suppression (at both 5 and 10%), we determined that only three lots could support a full dose-responsive suppression. Subsequently, in a comparison study between the effects of TCDD and the polyclonal B-cell activator Staphylococcus aureus Cowan Strain I (SAC) on the in vitro T-dependent humoral immune response, we have found that SAC suppresses the antibody response to SRBC and demonstrates the same serum dependency for this effect as was previously noted for TCDD. Under serum-free culturing conditions, TCDD (30 nM) caused a 15-fold increase in the AFC response to SRBCs over controls, suggesting that direct addition of TCDD to whole splenocyte cultures in the absence of serum-derived growth factors results in an increase in B-cell activation. Likewise, under serum-free conditions, SAC dose-dependently increased the AFC response over media controls, and at doses which achieved the same degree of suppression of the humoral response aa TCDD. Taken together, these studies suggest that TCDD has actions that are similar to a T cell independent polyclonal B cell activator such as SAC, and selectively acts on the B cell to suppress the T-dependent humoral immune response by a mechanism which is unique to this series of compounds. This effect however, is only detectable under appropriate serum-supported (or serum-deficient) culture conditions as described.
我们已经确定,2,3,7,8-四氯二苯并对二恶英(TCDD)对体外T细胞依赖的体液免疫反应的抑制作用取决于培养基中所用血清的类型和浓度。在23个商业批次的血清中(5%和10%浓度下均进行了筛选),只有5个批次能够在存在30 nM TCDD的情况下支持抑制作用,其余批次则表现出对TCDD暴露的明显“保护样”效应。当在含有支持抑制作用的每个血清批次(5%和10%浓度下)的培养基中用TCDD(0.3、3.0和30 nM)建立对数剂量反应曲线时,我们确定只有3个批次能够支持完全的剂量反应性抑制。随后,在一项关于TCDD和多克隆B细胞激活剂金黄色葡萄球菌考恩I株(SAC)对体外T细胞依赖的体液免疫反应影响的比较研究中,我们发现SAC抑制对绵羊红细胞(SRBC)的抗体反应,并且该效应表现出与先前TCDD所观察到的相同的血清依赖性。在无血清培养条件下,TCDD(30 nM)使对SRBC的抗体形成细胞(AFC)反应比对照增加了15倍,这表明在没有血清衍生生长因子的情况下,直接向全脾细胞培养物中添加TCDD会导致B细胞活化增加。同样,在无血清条件下,SAC剂量依赖性地增加了AFC反应,且达到了与TCDD相同程度的体液反应抑制剂量。综上所述,这些研究表明,TCDD具有与T细胞非依赖性多克隆B细胞激活剂(如SAC)相似的作用,并通过这一系列化合物特有的机制选择性地作用于B细胞以抑制T细胞依赖的体液免疫反应。然而,这种效应只有在如所述的适当血清支持(或血清缺乏)培养条件下才能检测到。